Infections with Clostridioides difficile (CDI) remain a significant cause of morbidity and mortality despite recent decreases in reported rates. A key element in in prevention of CDI transmission that warrants greater scrutiny is patient bathing. The rationale behind the practice of patient bathing in CDI transmission prevention is to reduce the spore bioburden on skin, yet studies of the two most common bathing agents—soap/water and chlorhexidine gluconate (CHG)—have demonstrated little to no benefit in achieving this goal. In choosing a product for bathing patients with CDI, careful consideration should be given to the product’s efficacy against Clostridioides difficile spores, potential for adverse events, compatibility with both different body areas and overall skin health, and contribution to the development of resistance. A better understanding of the available evidence as well as the factors involved in supporting the skin’s natural immunity can help inform clinician’s decisions in selecting a product. For more information, visit www.theraworxprotect.com.
To download the PDF file file for ‘ Clostridioides difficile Infection Prevention: the Role of Patient Bathing and Issues with Current Practice’, please provide us with your contact information below.